Corrigendum: Cost-Effective, Safe, and Personalized Cell Therapy for Critical Limb Ischemia in Type 2 Diabetes Mellitus - Soria-Juan, Bárbara; Escacena, Natalia; Capilla-González, Vivian; Aguilera, Yolanda; Llanos, Lucía; Tejedo, Juan R.; Bedoya, Francisco J.; Juan, Verónica; De la Cuesta, Antonio; Ruiz-Salmerón, Rafael; Andreu, Enrique; Grochowicz, Lukas; et al. (Frontiers in Immunology, 2020)